2005 Annual Meeting | Update in Childhood Headache

Date Friday 04/15/05

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN

Topic(s) Headache/Other Pain Syndromes

Learning Objectives Upon completion:
Participants should be able to utilize the new ICHD-II criteria to accurately diagnosis childhood headache disorders; develop effective treatment approaches for their own patients based on the most up-to-date data, while being able to base this decision on the underlying pathophysiology; and develop an understanding of the significant impact of the headaches on the child's and parents' lives and how to easily measure this in their own practice.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:05 AM		Introduction Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN
09:05 AM - 09:20 PM		Why Treat Kids Headaches: The Role of Disability and Quality of Life Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN
09:20 AM - 09:45 PM		ICDH-II Criteria and Epidemiolgy: How Has it all Been Changed? Paul Winner, DO, FAAN
09:45 AM - 10:15 AM		Pathophysiology: From Cortical Hypersensitivity to Genomics Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN
10:15 AM - 10:30 AM		Break
10:30 AM - 11:00 AM		Practice Parameters: Applying the What We Know Now Donald W. Lewis, MD, FAAP
11:00 AM - 11:30 AM		Acute Treatment: What's New and What's on the Horizon Steven L. Linder, MD
11:30 AM - 12:00 PM		Preventative Treatments: Why Prevent Headaches and What Works Marcy E. Yonker, MD
12:00 PM - 12:30 PM		From the ED to Inpatient: What to do When the Headaches Get Really Bad Marielle K. Samaha, MD, FAHS, FAAN, FAAN
12:30 PM - 12:45 PM		Questions and Answers: Applying This to Your Practice

Faculty Disclosures
Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN	The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Steven L. Linder, MD	No disclosure on file
Paul Winner, DO, FAAN	Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. The institution of Dr. Winner has received research support from Amgen. The institution of Dr. Winner has received research support from Allergan. The institution of Dr. Winner has received research support from Lundbeck . The institution of Dr. Winner has received research support from Novartis. The institution of Dr. Winner has received research support from Lilly. The institution of Dr. Winner has received research support from Teva. The institution of Dr. Winner has received research support from Supernus. The institution of Dr. Winner has received research support from Biogen. The institution of Dr. Winner has received research support from Avinar. The institution of Dr. Winner has received research support from SAMUS.
Marielle K. Samaha, MD, FAHS, FAAN, FAAN	Dr. Samaha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for theranica. Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAN . The institution of Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAP.
Marcy E. Yonker, MD	The institution of Dr. Yonker has received research support from NINDS. The institution of Dr. Yonker has received research support from PCORI. The institution of Dr. Yonker has received research support from TEVA. The institution of Dr. Yonker has received research support from AMGEN. The institution of Dr. Yonker has received research support from Pfizer. The institution of Dr. Yonker has received research support from Lilly. The institution of Dr. Yonker has received research support from Abbvie.
Donald W. Lewis, MD, FAAP	No disclosure on file

��ɫ��

��ɫ��